AnaptysBio, Inc. ANAB License — Revenue
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by AnaptysBio, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The source filing: AnaptysBio, Inc.’s 10-Q, filed May 12, 2026.
- Filed
- May 12, 2026, 4:20 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-219515
Pursuant to the terms of the Vanda License Agreement, we received an upfront payment of $10.0 million for the license and a $5.0 million payment for existing drug supply. We allocated the total transaction price of $15.0 million on a relative standalone selling price in accordance with ASC 606. During the three months ended March 31, 2026, we recognized no license revenue and less than $0.1 million of transition services revenue. During the three months ended March 31, 2025, we recognized $9.6 million of license revenue and $0.1 million of transition services revenue, under ASC 606, and recognized $1.9 million related to existing drug supply transferred to Vanda, under ASC 610. We expensed the $2.5 million of related transaction costs within general and administrative
Item 1. Consolidated Financial Statements
FAQ
- What is AnaptysBio, Inc.'s license — revenue?
- AnaptysBio, Inc. (ANAB) reported license — revenue of $0 in Q1 2026.
- How has AnaptysBio, Inc.'s license — revenue changed year-over-year?
- AnaptysBio, Inc.'s license — revenue decreased by 100.0% year-over-year, from $9.6M to $0.
- What does license — revenue mean?
- This metric captures the total revenue recognized from licensing intellectual property or technology rights to third-party customers, excluding any pass-through taxes. It serves as a primary indicator of the commercial value of the company's proprietary antibody pipeline and research platform. Monitoring this figure helps stakeholders evaluate the success of the company's business model in converting clinical-stage assets into contractual revenue streams.
Ask your AI about AnaptysBio, Inc.'s license — revenue.
Connect your AI assistant and compare it to peers, right in your chat.
